Role of Eosinophil-chemotactic C-C Chemokines in Cutaneous Inflammation
Overview
Affiliations
In the dermal sites of atopic skin, eosinophil (Eo) granule protein or more rarely intact Eos represent a characteristic histological feature. We addressed the question of whether lesional scales of patients with various eosinophilic skin disorders contain Eo attractant and tried to characterize it biochemically. In scales of a patient with drug reaction, heparin-binding Eo attractants could be identified. High-performance liquid chromatographic analyses together with specific ELISA and Western blot analyses revealed identity with RANTES. No other heparin-binding Eo chemotaxin could be identified. HPLC analysis of pooled lesional scale extracts of patients with atopic dermatitis showed fractions containing only weak heparin-binding Eo-chemotactic activity, which, however, showed RANTES immunoreactivity. In experiments to elucidate the putative cellular origin of Eo-attracting chemokines in human skin we investigated supernatants of atopic skin we investigated supernatants of atopic skin-derived T lymphocytes as well as supernatants of stimulated dermal fibroblasts for Eo-chemotactic factors. Unexpectedly, we did not find any heparin-bound Eo attractants in supernatants of stimulated cultured atopic skin-derived T lymphocyte clones, whereas fibroblasts produced RANTES as well as granulocyte-macrophage colony-stimulating factor. Therefore, fibroblasts are likely source of eosinophil attractant cells, which could contribute to the Eo infiltrate. Selectivity of the infiltrate might come from selective induction of RANTES and/or induction of other as yet unidentified Eo-specific chemokines.
Ahmadi Z, Hassanshahi G, Khorramdelazad H, Zainodini N, Koochakzadeh L Inflammation. 2016; 39(3):1253-67.
PMID: 26861136 DOI: 10.1007/s10753-016-0303-9.
Cellular aspects of atopic dermatitis.
Ou L, Huang J Clin Rev Allergy Immunol. 2007; 33(3):191-8.
PMID: 18163225 DOI: 10.1007/s12016-007-0045-4.
Lee J, Jung E, Kim Y, Lee J, Park J, Hong S Br J Pharmacol. 2006; 148(3):366-75.
PMID: 16604092 PMC: 1751564. DOI: 10.1038/sj.bjp.0706728.
Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions.
Kirkaldy A, Musonda A, Khanolkhar-Young S, Suneetha S, Lockwood D Clin Exp Immunol. 2003; 134(3):447-53.
PMID: 14632750 PMC: 1808882. DOI: 10.1111/j.1365-2249.2003.02306.x.
Alessandri A, Pinho V, Souza D, Castro M, Klein A, Teixeira M Br J Pharmacol. 2003; 140(5):847-54.
PMID: 14585802 PMC: 1574105. DOI: 10.1038/sj.bjp.0705515.